Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Abstract: The present disclosure generally relates to field emission cathode structure for a field emission arrangement, specifically adapted for enhance reliability and prolong the lifetime of the field emission arrangement by arranging a getter element underneath a gas permeable portion of the field emission cathode structure. The present disclosure also relates to a field emission lighting arrangement comprising such a field emission cathode structure and to a field emission lighting system.

Abstract: The present invention generally relates to a method for operating a plurality of field emission light sources, specifically for performing a testing procedure in relation to a plurality of field emission light sources manufactured in a chip based fashion. The invention also relates to a corresponding testing system.

Abstract: The present invention generally relates to a method for operating a plurality of field emission light sources, specifically for performing a testing procedure in relation to a plurality of field emission light sources manufactured in a chip based fashion. The invention also relates to a corresponding testing system.

Abstract: The present disclosure generally relates to field emission cathode structure for a field emission arrangement, specifically adapted for enhance reliability and prolong the lifetime of the field emission arrangement by arranging a getter element underneath a gas permeable portion of the field emission cathode structure. The present disclosure also relates to a field emission lighting arrangement comprising such a field emission cathode structure and to a field emission lighting system.

Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Abstract: Techniques for converting mechanical markings on hardcopy textual content into digital annotations in a digital document file. In accordance with some embodiments, the techniques include identifying at least one block of text in a digital (scanned) image of a hardcopy document, and identifying at least one mechanical marking in the digital image of the hardcopy document. The mechanical marking, such as an underline, strike-through, highlight or circle, covers or lies adjacent to the corresponding block of text. An annotated digital document file is generated from the digital image of the hardcopy document. The annotated digital document file includes computer-executable instructions representing the original text of the hardcopy document and at least one annotation corresponding to the mechanical marking in the hardcopy document.

Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Abstract: A DNS proxy may tag DNS requests from a virtual network with a separating identifier, such as a virtual network ID, before forwarding them to a shared DNS server. This can allow each virtual network to have its own namespace and avoid naming conflicts. The shared DNS server can examine the tagged DNS requests to respond to the DNS requests using the local namespace as identified by the separating identifier.

Abstract: Techniques for converting mechanical markings on hardcopy textual content into digital annotations in a digital document file. In accordance with some embodiments, the techniques include identifying at least one block of text in a digital (scanned) image of a hardcopy document, and identifying at least one mechanical marking in the digital image of the hardcopy document. The mechanical marking, such as an underline, strike-through, highlight or circle, covers or lies adjacent to the corresponding block of text. An annotated digital document file is generated from the digital image of the hardcopy document. The annotated digital document file includes computer-executable instructions representing the original text of the hardcopy document and at least one annotation corresponding to the mechanical marking in the hardcopy document.

Abstract: The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.

Abstract: A DNS proxy may tag DNS requests from a virtual network with a separating identifier, such as a virtual network ID, before forwarding them to a shared DNS server. This can allow each virtual network to have its own namespace and avoid naming conflicts. The shared DNS server can examine the tagged DNS requests to respond to the DNS requests using the local namespace as identified by the separating identifier.

Abstract: This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists.

Abstract: This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists.

Abstract: The present invention provides a method for treating and/or preventing hepatic disease conditions in a subject mammals including human beings, said method comprising the steps of administering to the mammal an effective dosage of composition comprising 2?-p-Hydroxy benzoyl mussaenosidic acid from plant Vitex negundo optionally as individual or in combination with one or more pharmaceutically additives.

Abstract: The present invention provides a method for treating and/or preventing hepatic disease conditions in a subject mammals including human beings, said method comprising the steps of administering to the mammal an effective dosage of composition comprising 2′-p-Hydroxy benzoyl mussaenosidic acid from plant Vitex negundo optionally as individual or in combination with one or more pharmaceutically additives.